Tags

Type your tag names separated by a space and hit enter

Exploit T cell Immunity for Rapid, Safe and Effective COVID-19 Vaccines.
Expert Rev Vaccines. 2020 09; 19(9):781-784.ER

Links

Publisher Full Text (DOI)

Authors+Show Affiliations

Moise L
EpiVax, Inc ., Providence, RI, USA. Institute for Immunology and Informatics, University of Rhode Island , Providence, RI, USA. Center for Vaccines and Immunology, University of Georgia , Athens, GA, USA.
Ross TM
Center for Vaccines and Immunology, University of Georgia , Athens, GA, USA.
Hoft DF
Departments of Molecular Microbiology & Immunology and Internal Medicine, Division of Infectious Diseases, Allergy & Immunology, Saint Louis University , St. Louis, MO, USA.
Martin WD
EpiVax, Inc ., Providence, RI, USA.
De Groot AS
EpiVax, Inc ., Providence, RI, USA. Center for Vaccines and Immunology, University of Georgia , Athens, GA, USA.

MeSH

BetacoronavirusCOVID-19COVID-19 VaccinesCoronavirus InfectionsHumansPandemicsPneumonia, ViralSARS-CoV-2T-LymphocytesViral Vaccines

Pub Type(s)

Editorial

Language

eng

PubMed ID

32962468

Citation

Moise, Leonard, et al. "Exploit T Cell Immunity for Rapid, Safe and Effective COVID-19 Vaccines." Expert Review of Vaccines, vol. 19, no. 9, 2020, pp. 781-784.
Moise L, Ross TM, Hoft DF, et al. Exploit T cell Immunity for Rapid, Safe and Effective COVID-19 Vaccines. Expert Rev Vaccines. 2020;19(9):781-784.
Moise, L., Ross, T. M., Hoft, D. F., Martin, W. D., & De Groot, A. S. (2020). Exploit T cell Immunity for Rapid, Safe and Effective COVID-19 Vaccines. Expert Review of Vaccines, 19(9), 781-784. https://doi.org/10.1080/14760584.2020.1825946
Moise L, et al. Exploit T Cell Immunity for Rapid, Safe and Effective COVID-19 Vaccines. Expert Rev Vaccines. 2020;19(9):781-784. PubMed PMID: 32962468.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Exploit T cell Immunity for Rapid, Safe and Effective COVID-19 Vaccines. AU - Moise,Leonard, AU - Ross,Ted M, AU - Hoft,Daniel F, AU - Martin,William D, AU - De Groot,Anne S, Y1 - 2020/10/06/ PY - 2020/9/24/pubmed PY - 2020/11/28/medline PY - 2020/9/23/entrez KW - COVID-19 KW - SARS-CoV-2 KW - T cell KW - T cell epitope KW - antibody KW - coronavirus KW - vaccine SP - 781 EP - 784 JF - Expert review of vaccines JO - Expert Rev Vaccines VL - 19 IS - 9 SN - 1744-8395 UR - https://www.unboundmedicine.com/medline/citation/32962468/Exploit_T_cell_Immunity_for_Rapid_Safe_and_Effective_COVID_19_Vaccines_ DB - PRIME DP - Unbound Medicine ER -